Murine-and human-derived autologous organoid/immune cell co-cultures as pre-clinical models of pancreatic ductal adenocarcinoma

L Holokai, J Chakrabarti, J Lundy, D Croagh… - Cancers, 2020 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal
malignancies, with an approximate 10% five-year survival rate despite therapy. A plausible …

[HTML][HTML] NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with …

M Sendler, C van den Brandt, J Glaubitz, A Wilden… - Gastroenterology, 2020 - Elsevier
Background & Aims Pancreatitis starts with primarily sterile local inflammation that induces
systemic inflammatory response syndrome, followed by compensatory anti-inflammatory …

NLRP6: a multifaceted innate immune sensor

M Levy, H Shapiro, CA Thaiss, E Elinav - Trends in Immunology, 2017 - cell.com
NLRP6, a member of the nucleotide-binding domain, leucine-rich repeat-containing (NLR)
innate immune receptor family, regulates inflammation and host defense against …

NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets

C Hu, H Ding, Y Li, JA Pearson… - Proceedings of the …, 2015 - National Acad Sciences
Studies in animal models and human subjects have shown that both innate and adaptive
immunity contribute to the pathogenesis of type 1 diabetes (T1D). Whereas the role of TLR …

NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling

IC Allen, JE Wilson, M Schneider, JD Lich, RA Roberts… - Immunity, 2012 - cell.com
In vitro data suggest that a subgroup of NLR proteins, including NLRP12, inhibits the
transcription factor NF-κB, although physiologic and disease-relevant evidence is largely …

NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen

S Nordlander, J Pott, KJ Maloy - Mucosal immunology, 2014 - nature.com
The inflammasomes have an important role in connecting the detection of endogenous and
microbial danger signals to caspase-1 activation and induction of protective immune …

NLRP3: a promising therapeutic target for autoimmune diseases

HH Shen, YX Yang, X Meng, XY Luo, XM Li… - Autoimmunity …, 2018 - Elsevier
NLRP3, a member of nucleotide-binding domain-(NOD) like receptor family, can be found in
large varieties of immune and non-immune cells. Upon activation, the NLRP3, apoptosis …

The MLL1-H3K4me3 axis-mediated PD-L1 expression and pancreatic cancer immune evasion

C Lu, AV Paschall, H Shi, N Savage… - JNCI: journal of the …, 2017 - academic.oup.com
Background: Pancreatic cancer is one of the cancers where anti-PD-L1/PD-1
immunotherapy has been unsuccessful. What confers pancreatic cancer resistance to …

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma… - Nature medicine, 2009 - nature.com
The therapeutic efficacy of anticancer chemotherapies may depend on dendritic cells (DCs),
which present antigens from dying cancer cells to prime tumor-specific interferon-γ (IFN-γ) …

The innate immune receptor NLRX1 functions as a tumor suppressor by reducing colon tumorigenesis and key tumor-promoting signals

AA Koblansky, AD Truax, R Liu, SA Montgomery… - Cell reports, 2016 - cell.com
NOD-like receptor (NLR) proteins are intracellular innate immune sensors/receptors that
regulate immunity. This work shows that NLRX1 serves as a tumor suppressor in colitis …